Lack of neuroprotection by an ACTH (4–9) analogue. A randomized trial in patients treated with vincristine for Hodgkin’s or non-Hodgkin’s lymphoma

By Koeppen S.   Verstappen C.   Körte R.   Scheulen M.   Strumberg D.   Postma T.   Heimans J.   Huijgens P.   Kiburg B.   Renzing-Köhler K.   Diener H.  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 3, 2004-03 ,pp. : 153-160

Springer Publishing Company

Access to resources Recommend Favorite

Primary gastrointestinal non-Hodgkin’s lymphoma: clinicopathological and prognostic analysis

By Wang Tong   Gui Wei   Shen Quanliang  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 661-666

Humana Press, Inc

Access to resources Recommend Favorite

Primary non-Hodgkin’s lymphoma of the bone: A single institution experience

By Deshmukh C.   Bakshi A.   Parikh P.   Nair R.   Pai V.   Gupta S.   Shaikh A.   Muckaden M.   Naresh K.   Saikia T.  

Medical Oncology, Vol. 21, Iss. 3, 2004-09 ,pp. : 263-267

Humana Press, Inc

Access to resources Recommend Favorite

Phase I trial of fludarabine and paclitaxel in non-hodgkin’s lymphoma

By Abbasi Muhammad   Sparano Joseph   Sarta Catherine   Wiernik Peter  

Medical Oncology, Vol. 20, Iss. 1, 2003-03 ,pp. : 53-58

Humana Press, Inc

Access to resources Recommend Favorite

Pralatrexate: treatment of T-cell non-Hodgkin’s lymphoma

By Parker Terri   Barbarotta Lisa   Foss Francine  

Future Oncology, Vol. 9, Iss. 1, 2013-01 ,pp. : 21-29

Future Medicine

Access to resources Recommend Favorite